Neurimmune Holding
Investor profile
Venture capital
Neurimmune Holding has backed 1 European tech company across 2 funding rounds between 2018 and 2026, joining rounds totalling €35M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
2
distinct rounds
Companies
1
backed
Active span
2018–2026
9 yrs
Total round €
€35M
sum of rounds joined
Deals by year
distinct rounds / yearNeurimmune Holding — deals by year — interactive chart.
Data table
| Neurimmune Holding — deals by year | |
|---|---|
| 2018 | 1 |
| 2026 | 1 |
Top sectors
by dealsNeurimmune Holding — top sectors — interactive chart.
Data table
| Neurimmune Holding — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsNeurimmune Holding — stages — interactive chart.
Data table
| Neurimmune Holding — stages | |
|---|---|
| Series A | 1 |
| Series B | 1 |
Countries
by dealsNeurimmune Holding — countries — interactive chart.
Data table
| Neurimmune Holding — countries | |
|---|---|
| Switzerland | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| NovaGo Therapeutics | Switzerland | 2 | €35M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| NovaGo Therapeutics | Series A | €8.9M | 2019-01 |